HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 608 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,448,911 | -84.2% | 72,425 | -82.6% | 0.29% | -83.7% |
| Q4 2022 | $47,233,031 | +3.9% | 415,053 | -43.5% | 1.78% | -4.1% |
| Q3 2022 | $45,449,000 | -35.0% | 734,353 | -16.2% | 1.86% | -32.2% |
| Q2 2022 | $69,877,000 | -30.8% | 876,089 | -8.7% | 2.75% | -22.5% |
| Q1 2022 | $100,943,000 | +4.4% | 959,439 | +6.9% | 3.54% | +13.9% |
| Q4 2021 | $96,719,000 | -3.0% | 897,540 | -1.4% | 3.11% | -3.1% |
| Q3 2021 | $99,719,000 | +13.7% | 910,340 | -2.8% | 3.21% | +12.7% |
| Q2 2021 | $87,679,000 | +17.5% | 936,340 | +15.5% | 2.85% | +11.0% |
| Q1 2021 | $74,638,000 | +119.4% | 810,932 | +74.4% | 2.57% | +114.8% |
| Q4 2020 | $34,016,000 | -27.5% | 465,016 | -23.0% | 1.20% | -32.0% |
| Q3 2020 | $46,894,000 | +105.7% | 603,684 | +47.2% | 1.76% | +102.4% |
| Q2 2020 | $22,796,000 | +92.8% | 410,153 | +2.7% | 0.87% | +62.2% |
| Q1 2020 | $11,826,000 | +7.2% | 399,257 | +31.0% | 0.54% | +28.3% |
| Q4 2019 | $11,029,000 | +88.6% | 304,664 | +41.9% | 0.42% | +63.5% |
| Q3 2019 | $5,847,000 | +54.3% | 214,730 | +36.4% | 0.26% | +64.5% |
| Q2 2019 | $3,789,000 | – | 157,473 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |